|
1）Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009; 41(5): 591-5. Epub 2009/04/08
|
|
|
|
2）Mbarek H, Ochi H, Urabe Y, et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Human Molecular Genetics. 2011; 20(19): 3884-92. Epub 2011/07/14
|
|
|
|
|
|
3）Nishida N, Sawai H, Matsuura K, et al. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PloS One. 2012; 7(6): e39175. Epub 2012/06/28
|
|
|
|
|
|
4）Png E, Thalamuthu A, Ong RT, et al. A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Human Molecular Genetics. 2011; 20(19): 3893-8. Epub 2011/07/19
|
|
|
|
|
|
5）An P, Winkler C, Guan L, et al. A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese. J Infect Dis. 2011; 203(7): 943-7. Epub 2011/03/16
|
|
|
|
|
|
6）Guo X, Zhang Y, Li J, et al. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology. 2011; 53(2): 422-8. Epub 2011/ 01/29
|
|
|
|
|
|
7）Li J, Yang D, He Y, et al. Associations of HLA-DP variants with hepatitis B virus infection in Southern and Northern Han Chinese populations: A Multicenter Case-Control Study. PloS One. 2011; 6(8): e24221. Epub 2011/09/10
|
|
|
|
|
|
8）Lampertico P, Vigano M, Cheroni C, et al. IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B. Hepatology. 2013; 57(3): 890-6. Epub 2012/04/05
|
|
|
|
|
|
9）Lampertico P, Galmozzi E, Colombo M. [In Process Citation]. Hepatology. 2013; 57(3): 1283-4. Epub 2012/06/19
|
|
|
|
|
|
10）Tseng TC, Yu ML, Liu CJ, et al. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-alpha-2a therapy. Antivir Ther. 2011; 16(5): 629-37. Epub 2011/08/06
|
|
|
|
|
|
11）Wu X, Xin Z, Zhu X, et al. Evaluation of susceptibility locus for response to interferon-alpha based therapy in chronic hepatitis B patients in Chinese. Antiviral Res. 2012; 93(2): 297-300. Epub 2012/01/03
|
|
|
|
|
|
12）Sonneveld MJ, Wong VW, Woltman AM, et al. Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B. Gastroenterology. 2012; 142(3): 513-20 e1. Epub 2011/11/24
|
|
|
|
|
|
13）Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 2012; 1: e00049. Epub 2012/11/15
|
|
|
|
|
|
14）Suchanek M, Radzikowska A, Thiele C. Photo-leucine and photo-methionine allow identification of protein-protein interactions in living cells. Nat Methods. 2005; 2(4): 261-7. Epub 2005/03/ 23
|
|
|
|
|
|
15）Yan RQ, Su JJ, Huang DR, et al. Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus. J Cancer Res Clin Oncol. 1996; 122(5): 283-8. Epub 1996/01/01
|
|
|
|
|
|
16）Kock J, Nassal M, MacNelly S, et al. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol. 2001; 75(11): 5084-9. Epub 2001/05/03
|
|
|
|
|
|
17）Gripon P, Rumin S, Urban S, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A. 2002; 99(24): 15655-60. Epub 2002/11/15
|
|
|
|
|
|
18）Pugh JC, Simmons H. Duck hepatitis B virus infection of Muscovy duck hepatocytes and nature of virus resistance in vivo. J Virol. 1994; 68(4): 2487-94. Epub 1994/04/01
|
|
|
|
|
|
19）Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology. 2007; 46(6): 1759-68. Epub 2007/11/30
|
|
|
|
|
|
20）Leistner CM, Gruen-Bernhard S, Glebe D. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol. 2008; 10(1): 122-33. Epub 2007/12/19
|
|
|
|
|
|
21）Sureau C, Salisse J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology. 2013; 57(3): 985-94. Epub 2012/11/20
|
|
|
|
|
|
22）Sung WK, Zheng H, Li S, et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 2012; 44(7): 765-9. Epub 2012/05/29
|
|
|
|
|